110. L. Zhou, T. Yang, J. Wang, Q. Wang, X. Lv, H. Ke et al., Size-tunable Gd 2 O 3 @ albumin
nanoparticles conjugating chlorin e6 for magnetic resonance imaging-guided photo-induced
therapy. Theranostics 7(3), 764 (2017)
111. T. Lin, P. Zhao, Y. Jiang, Y. Tang, H. Jin, Z. Pan et al., Blood–brain-barrier-penetrating
albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways
for antiglioma therapy. ACS Nano 10(11), 9999–10012 (2016)
112. A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, S.W. Joo, N. Zarghami, Y. Hanifehpour
et al., Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 8(1), 102
(2013)
113. T.M. Allen, P.R. Cullis, Liposomal drug delivery systems: from concept to clinical
applications. Adv. Drug Deliv. Rev. 65(1), 36–48 (2013)
114. Y. Xia, J. Tian, X. Chen, Effect of surface properties on liposomal siRNA delivery.
Biomaterials 79, 56–68 (2016)
115. S. Hu, M. Niu, F. Hu, Y. Lu, J. Qi, Z. Yin et al., Integrity and stability of oral liposomes
containing bile salts studied in simulated and ex vivo gastrointestinal media. Int. J. Pharm.
441(1), 693–700 (2013)
116. Y.-Y. Lin, J.-J. Li, C.-H. Chang, Y.-C. Lu, J.-J. Hwang, Y.-L. Tseng et al., Evaluation of
pharmacokinetics of
111
In-labeled VNB-PEGylated liposomes after intraperitoneal and
intravenous administration in a tumor/ascites mouse model. Cancer Biother. Radiopharm.
24(4), 453–460 (2009)
117. J.W. Seo, H. Zhang, D.L. Kukis, C.F. Meares, K.W. Ferrara, A novel method to label
preformed liposomes with
64
Cu for positron emission tomography (PET) imaging.
Bioconjug. Chem. 19(12), 2577–2584 (2008)
118. J. Kim, D.N. Pandya, W. Lee, J.W. Park, Y.J. Kim, W. Kwak et al., Vivid tumor imaging
utilizing liposome-carried bimodal radiotracer. ACS Med. Chem. Lett. 5(4), 390–394 (2014)
119. T.X. Nguyen, L. Huang, M. Gauthier, G. Yang, Q. Wang, Recent advances in liposome
surface modification for oral drug delivery. Nanomedicine 11(9), 1169–1185 (2016)
120. Y.-B. Huang, M.-J. Tsai, P.-C. Wu, Y.-H. Tsai, Y.-H. Wu, J.-Y. Fang, Elastic liposomes as
carriers for oral delivery and the brain distribution of (+)-catechin. J. Drug Target 19(8),
709–718 (2011)
121. S. Jain, S.R. Patil, N.K. Swarnakar, A.K. Agrawal, Oral delivery of doxorubicin using novel
polyelectrolyte-stabilized liposomes (layersomes). Mol. Pharm. 9(9), 2626–2635 (2012)
122. S. Edmonds, A. Volpe, H. Shmeeda, A.C. Parente-Pereira, R. Radia, J. Baguna-Torres et al.,
Exploiting the metal-chelating properties of the drug cargo for in vivo positron emission
tomography imaging of liposomal nanomedicines. ACS Nano 10(11), 10294–10307 (2016)
123. L. Feng, L. Cheng, Z. Dong, D. Tao, T.E. Barnhart, W. Cai et al., Theranostic liposomes
with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic
therapy. ACS Nano 11(1), 927–937 (2017)
124. N. Li, Z. Yu, T.T. Pham, P.J. Blower, R. Yan, A generic
89
Zr labeling method to quantify the
in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography. Int.
J. Nanomed. 12, 3281–3294 (2017)
125. H. Xing, C.L. Zhang, G. Ruan, J. Zhang, K. Hwang, Y. Lu, Multimodal detection of a small
molecule target using stimuli-responsive liposome triggered by aptamer-enzyme conjugate.
Anal. Chem. 88(3), 1506–1510 (2016)
126. A.L. Petersen, T. Binderup, P. Rasmussen, J.R. Henriksen, D.R. Elema, A. Kjær et al.,
64
Cu
loaded liposomes as positron emission tomography imaging agents. Biomaterials 32(9),
2334–2341 (2011)
127. Y. Du, X. Liang, Y. Li, T. Sun, Z. Jin, H. Xue et al., Nuclear and fluorescent labeled
PD-1-liposome-DOX64
Cu/IRDye800CW allows improved breast tumor targeted imaging
and therapy. Mol. Pharm. (2017) (Epub)
128. C. Rangger, A. Helbok, J. Sosabowski, C. Kremser, G. Koehler, R. Prassl et al., Tumor
targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Int. J. Nanomed. 8, 4659–4671 (2013)
206
D. Chen and H. Hong
nanoparticles conjugating chlorin e6 for magnetic resonance imaging-guided photo-induced
therapy. Theranostics 7(3), 764 (2017)
111. T. Lin, P. Zhao, Y. Jiang, Y. Tang, H. Jin, Z. Pan et al., Blood–brain-barrier-penetrating
albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways
for antiglioma therapy. ACS Nano 10(11), 9999–10012 (2016)
112. A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, S.W. Joo, N. Zarghami, Y. Hanifehpour
et al., Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 8(1), 102
(2013)
113. T.M. Allen, P.R. Cullis, Liposomal drug delivery systems: from concept to clinical
applications. Adv. Drug Deliv. Rev. 65(1), 36–48 (2013)
114. Y. Xia, J. Tian, X. Chen, Effect of surface properties on liposomal siRNA delivery.
Biomaterials 79, 56–68 (2016)
115. S. Hu, M. Niu, F. Hu, Y. Lu, J. Qi, Z. Yin et al., Integrity and stability of oral liposomes
containing bile salts studied in simulated and ex vivo gastrointestinal media. Int. J. Pharm.
441(1), 693–700 (2013)
116. Y.-Y. Lin, J.-J. Li, C.-H. Chang, Y.-C. Lu, J.-J. Hwang, Y.-L. Tseng et al., Evaluation of
pharmacokinetics of
111
In-labeled VNB-PEGylated liposomes after intraperitoneal and
intravenous administration in a tumor/ascites mouse model. Cancer Biother. Radiopharm.
24(4), 453–460 (2009)
117. J.W. Seo, H. Zhang, D.L. Kukis, C.F. Meares, K.W. Ferrara, A novel method to label
preformed liposomes with
64
Cu for positron emission tomography (PET) imaging.
Bioconjug. Chem. 19(12), 2577–2584 (2008)
118. J. Kim, D.N. Pandya, W. Lee, J.W. Park, Y.J. Kim, W. Kwak et al., Vivid tumor imaging
utilizing liposome-carried bimodal radiotracer. ACS Med. Chem. Lett. 5(4), 390–394 (2014)
119. T.X. Nguyen, L. Huang, M. Gauthier, G. Yang, Q. Wang, Recent advances in liposome
surface modification for oral drug delivery. Nanomedicine 11(9), 1169–1185 (2016)
120. Y.-B. Huang, M.-J. Tsai, P.-C. Wu, Y.-H. Tsai, Y.-H. Wu, J.-Y. Fang, Elastic liposomes as
carriers for oral delivery and the brain distribution of (+)-catechin. J. Drug Target 19(8),
709–718 (2011)
121. S. Jain, S.R. Patil, N.K. Swarnakar, A.K. Agrawal, Oral delivery of doxorubicin using novel
polyelectrolyte-stabilized liposomes (layersomes). Mol. Pharm. 9(9), 2626–2635 (2012)
122. S. Edmonds, A. Volpe, H. Shmeeda, A.C. Parente-Pereira, R. Radia, J. Baguna-Torres et al.,
Exploiting the metal-chelating properties of the drug cargo for in vivo positron emission
tomography imaging of liposomal nanomedicines. ACS Nano 10(11), 10294–10307 (2016)
123. L. Feng, L. Cheng, Z. Dong, D. Tao, T.E. Barnhart, W. Cai et al., Theranostic liposomes
with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic
therapy. ACS Nano 11(1), 927–937 (2017)
124. N. Li, Z. Yu, T.T. Pham, P.J. Blower, R. Yan, A generic
89
Zr labeling method to quantify the
in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography. Int.
J. Nanomed. 12, 3281–3294 (2017)
125. H. Xing, C.L. Zhang, G. Ruan, J. Zhang, K. Hwang, Y. Lu, Multimodal detection of a small
molecule target using stimuli-responsive liposome triggered by aptamer-enzyme conjugate.
Anal. Chem. 88(3), 1506–1510 (2016)
126. A.L. Petersen, T. Binderup, P. Rasmussen, J.R. Henriksen, D.R. Elema, A. Kjær et al.,
64
Cu
loaded liposomes as positron emission tomography imaging agents. Biomaterials 32(9),
2334–2341 (2011)
127. Y. Du, X. Liang, Y. Li, T. Sun, Z. Jin, H. Xue et al., Nuclear and fluorescent labeled
PD-1-liposome-DOX64
Cu/IRDye800CW allows improved breast tumor targeted imaging
and therapy. Mol. Pharm. (2017) (Epub)
128. C. Rangger, A. Helbok, J. Sosabowski, C. Kremser, G. Koehler, R. Prassl et al., Tumor
targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Int. J. Nanomed. 8, 4659–4671 (2013)
206
D. Chen and H. Hong